BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 155429)

  • 21. Cardiac involvement in Fukuyama-type congenital muscular dystrophy.
    Nakanishi T; Sakauchi M; Kaneda Y; Tomimatsu H; Saito K; Nakazawa M; Osawa M
    Pediatrics; 2006 Jun; 117(6):e1187-92. PubMed ID: 16717122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Enzyme histochemistry in the biopsy diagnosis of skeletal muscle diseases].
    Gullotta F
    Acta Histochem Suppl; 1983; 28():75-84. PubMed ID: 6412312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case of myopathy associated with a dystrophin gene deletion and abnormal glycogen storage.
    Rose MR; Howard RS; Genet SA; McMahon CJ; Whitfield A; Morgan-Hughes JA
    Muscle Nerve; 1993 Jan; 16(1):57-62. PubMed ID: 8423832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Glycogen storage disease, type VII. Muscular phosphofructokinase deficiency].
    Tarui S
    Saishin Igaku; 1969 Jun; 24(6):1235-46. PubMed ID: 4241020
    [No Abstract]   [Full Text] [Related]  

  • 25. New type of X-linked progressive muscular dystrophy involving shoulder girdle and back.
    Ji XW; Tan J; Chen XY; Yi SX; Liang H
    Am J Med Genet; 1990 Oct; 37(2):209-12. PubMed ID: 2248287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ultrastructure of skeletal muscle in muscular dystrophy, the carrier state and other human myopathies.
    Papadimitriou JM; Kakulas BA
    Proc Aust Assoc Neurol; 1968; 5(1):87-94. PubMed ID: 5250033
    [No Abstract]   [Full Text] [Related]  

  • 27. Congenital muscular dystrophy with primary laminin alpha2 (merosin) deficiency presenting as inflammatory myopathy.
    Pegoraro E; Mancias P; Swerdlow SH; Raikow RB; Garcia C; Marks H; Crawford T; Carver V; Di Cianno B; Hoffman EP
    Ann Neurol; 1996 Nov; 40(5):782-91. PubMed ID: 8957020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the enzymatic defect in late-onset muscle phosphofructokinase deficiency. New subtype of glycogen storage disease type VII.
    Vora S; DiMauro S; Spear D; Harker D; Danon MJ
    J Clin Invest; 1987 Nov; 80(5):1479-85. PubMed ID: 2960695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fatal infantile form of muscle phosphofructokinase deficiency.
    Servidei S; Bonilla E; Diedrich RG; Kornfeld M; Oates JD; Davidson M; Vora S; DiMauro S
    Neurology; 1986 Nov; 36(11):1465-70. PubMed ID: 2945125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Muscle phosphofructokinase deficiency in a myopathic child with severe mental retardation and aplasia of cerebellar vermis.
    Pastoris O; Dossena M; Vercesi L; Scelsi R; Torcetta F; Savasta S; Bianchi E
    Childs Nerv Syst; 1992 Jun; 8(4):237-41. PubMed ID: 1394261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Muscle phosphofructokinase deficiency in man: expression of the defect in blood cells and cultured fibroblasts.
    Kahn A; Weil D; Cottreau D; Dreyfus JC
    Ann Hum Genet; 1981 Feb; 45(1):5-14. PubMed ID: 6459054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erythrocyte phosphofructokinase deficiency associated with an unstable variant of muscle phosphofructokinase.
    Kahn A; Etiemble J; Meienhofer MC; Bovin P
    Clin Chim Acta; 1975 Jun; 61(3):415-9. PubMed ID: 125160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Late-onset muscle phosphofructokinase deficiency.
    Danon MJ; Servidei S; DiMauro S; Vora S
    Neurology; 1988 Jun; 38(6):956-60. PubMed ID: 2966901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two cases of phosphofructokinase deficiency associated with congenital hemolytic anemia found in Japan.
    Tani K; Fujii H; Takegawa S; Miwa S; Koyama W; Kanayama M; Imanaka A; Imanaka F; Kuramoto A
    Am J Hematol; 1983 Apr; 14(2):165-74. PubMed ID: 6220601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apparent absence of glycogen branching enzyme activity in phosphofructokinase deficiency.
    Barash V; Lilling S; Fischer R; Argov Z
    J Inherit Metab Dis; 1991; 14(6):902-7. PubMed ID: 1838126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipid peroxidation and superoxide dismutase activity in muscle and erythrocytes in Duchenne muscular dystrophy.
    Mechler F; Imre S; Dioszeghy P
    J Neurol Sci; 1984 Mar; 63(3):279-83. PubMed ID: 6726273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polysaccharide storage myopathy in canine phosphofructokinase deficiency (type VII glycogen storage disease).
    Harvey JW; Calderwood Mays MB; Gropp KE; Denaro FJ
    Vet Pathol; 1990 Jan; 27(1):1-8. PubMed ID: 2137952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemical studies of canine muscle phosphofructokinase deficiency.
    Giger U; Kelly AM; Teno PS
    Enzyme; 1988; 40(1):25-9. PubMed ID: 2971529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Type VII glycogenosis (muscle and erythrocyte phosphofructokinase deficiency).
    Tarui S; Kono N; Kuwajima M; Ikura Y
    Monogr Hum Genet; 1978; 9():42-7. PubMed ID: 153468
    [No Abstract]   [Full Text] [Related]  

  • 40. A genetic defect in muscle phosphofructokinase deficiency, a typical clinical entity presenting myogenic hyperuricemia.
    Nakajima H; Kono N; Yamasaki T; Hotta K; Kawachi M; Hamaguchi T; Nishimura T; Mineo I; Kuwajima M; Noguchi T
    Adv Exp Med Biol; 1991; 309B():141-4. PubMed ID: 1838230
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.